Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: A systematic review

Neonatology

Volumn 98, Issue 3, 2010, Pages 217-224

  Doyle, Lex W ^a,d   Ehrenkranz, Richard A ^b   Halliday, Henry L ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

BPD, preterm infants; Bronchopulmonary dysplasia; Cerebral palsy; Dexamethasone; Mortality rate

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

CEREBRAL PALSY; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DEATH; DRUG EFFECT; EARLY INTERVENTION; EXTUBATION; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INTESTINE PERFORATION; LUNG DYSPLASIA; META ANALYSIS; MORBIDITY; MORTALITY; NEWBORN DISEASE; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

AGE FACTORS; BRONCHOPULMONARY DYSPLASIA; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77950609123     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000286210     Document Type: Review

References (40)

1. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K: Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353-1360.
2. Speer CP: Chorioamniotitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009; 95: 353-361.
3. Watterberg KL, Gerdes JS, Gifford KL, Lin HM: Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999; 104: 1258-1263.
4. American Academy of Pediatrics, Committee on Fetus and Newborn, and Canadian Paediatric Society, Fetus and Newborn Committee: Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109: 330-338.
5. Halliday HL, Ehrenkranz RA, Doyle LW: Early ( ! 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2009:CD001146.
6. Doyle LW, Ehrenkranz RA, Halliday HL: Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology 2010;98:111-117.
7. Halliday HL, Ehrenkranz RA, Doyle LW: Late ( 1 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2009:CD001145.
8. Doyle LW, Halliday HL, Ehrenkranz RA: Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology 2010, in press.
9. Higgins JPT, Green S: Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). Higgins JPT, Green S (eds): The Cochrane Collaboration, 2008. Available from www.cochranehandbook. org.
10. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH: Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004; 350: 1304-1313.
11. Stanley FJ: Using cerebral palsy data in the evaluation of neonatal intensive care: a warning. Dev Med Child Neurol 1982; 24: 93-94.
12. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, Hsieh WS, Lien YJ: Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 1998; 101:E7.
13. Bassler D, Halliday HL, Plavka R, Hallman M, Shinwell ES, Jarreau PH, Carnielli V, van den Anker J, Schwab M, Poets CF: The Neonatal European Study of Inhaled Steroids (NEUROSIS): An EU-funded international randomised controlled trial in preterm infants. Neonatology 2009; 97: 52-55.
14. Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC: Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics 2005; 115: 655-661.
15. Soll RF: Current trials in the treatment of respiratory failure in preterm infants. Neonatology 2009; 95: 368-372.
16. Thomas W, Speer CP: Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia - what is the evidence? Neonatology 2008; 94: 150-159.
17. Schmidt B, Roberts R, Millar D, Kirpalani H: Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants. Neonatology 2008; 93: 284-287.
18. Halac E, Halac J, Begue EF, Casanas JM, Indiveri DR, Petit JF, Figueroa MJ, Olmas JM, Rodriguez LA, Obregon RJ, et al: Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. J Pediatr 1990; 117: 132-138.
19. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS: Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr 1990; 117: 273-282.
20. Sanders RJ, Cox C, Phelps DL, Sinkin RA: Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res 1994; 36: 122-128.
21. Shinwell ES, Karplus M, Zmora E, Reich D, Rothschild A, Blazer S, Bader D, Yurman S, Dolfin T, Kuint J, Milbauer B, Kohelet D, Goldberg M, Armon Y, Davidson S, Sirota L, Amitai M, Zaretsky A, Barak M, Gottfried S: Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 1996; 74:F33-F37.
22. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS: A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics 1996; 98: 204-210.
23. Wang JY, Yeh TF, Lin YC, Miyamura K, Holmskov U, Reid KB: Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Thorax 1996; 51: 907-913.
24. Suske G, Oestreich K, Varnholt V, Lasch P, Kachel W: Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant- substituted preterm infants. Acta Paediatr 1996; 85: 713-718.
25. Subhedar NV, Ryan SW, Shaw NJ: Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high-risk preterm infants. Arch Dis Child Fetal Neonatal Ed 1997; 77:F185-F190.
26. Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, Chien CH: Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics 1997; 100:E3.
27. Tapia JL, Ramirez R, Cifuentes J, Fabres J, Hubner ME, Bancalari A, Mercado ME, Standen J, Escobar M: The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. J Pediatr 1998; 132: 48-52.
28. Mukhopadhyay K, Kumar P, Narang A: Role of early postnatal dexamethasone in respiratory distress syndrome. Indian Pediatr 1998; 35: 117-122.
29. Garland JS, Alex CP, Pauly TH, Whitehead VL, Brand J, Winston JF, Samuels DP, McAuliffe TL: A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics 1999; 104: 91-99.
30. Kopelman AE, Moise AA, Holbert D, Hegemier SE: A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants. J Pediatr 1999; 135: 345-350.
31. Lin YJ, Yeh TF, Hsieh WS, Chi YC, Lin HC, Lin CH: Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy. Pediatr Pulmonol 1999; 27: 21-26.
32. Sinkin RA, Dweck HS, Horgan MJ, Gallaher KJ, Cox C, Maniscalco WM, Chess PR, D'Angio CT, Guillet R, Kendig JW, Ryan RM, Phelps DL: Early dexamethasone - attempting to prevent chronic lung disease. Pediatrics 2000; 105: 542-548.
33. Group TVONSS: Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatrics 2001; 108: 741-748.
34. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S, Donovan EF, Oh W, Bauer CR, Saha S, Poole WK, Stoll BJ: Adverse effects of early dexamethasone in extremely- low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 2001; 344: 95-101.
35. Vento G, Matassa PG, Zecca E, Tortorolo L, Martelli M, De Carolis MP, Maggio L, Zini G, D'Onofrio G, Valentini S, Romagnoli C: Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants. Pharmacology 2004; 71: 113-119.
36. Anttila E, Peltoniemi O, Haumont D, Herting E, ter Horst H, Heinonen K, Kero P, Nykanen P, Oetomo SB, Hallman M: Early neonatal dexamethasone treatment for prevention of bronchopulmonary dysplasia. Randomised trial and meta-analysis evaluating the duration of dexamethasone therapy. Eur J Pediatr 2005; 164: 472-481.
37. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, Arbel E, Goldberg M, Gur I, Naor N, Sirota L, Mogilner S, Zaritsky A, Barak M, Gottfried E: Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000; 83:F177-F181.
38. Romagnoli C, Zecca E, Vento G, De Carolis MP, Papacci P, Tortorolo G: Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants. Intensive Care Med 1999; 25: 717-721.
39. Romagnoli C, Zecca E, Luciano R, Torrioli G, Tortorolo G: Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up. Pediatrics 2002; 109:e85.
40. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S, Donovan EF, Oh W, Bauer CR, Saha S, Poole WK, Stoll BJ: NIoCHaHDNR Network: Neurodevelopmental outcome and growth at 18-22 months in infants treated with early dexamethasone. Pediatr Res 2001; 49: 388A.